Paper20099
Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata).
Vesely DL and 4 others. Biochem Biophys Res Commun, 1977. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata). Papers, record 20099. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20099
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata).
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzyme Inhibitors | Major topic |
| Guanylate Cyclase | Major topic |
| Plant Extracts | Major topic |
| Animals | |
| Fruit | |
| Liver | |
| Male | |
| Methylnitronitrosoguanidine | |
| Molecular Weight | |
| Plant Poisoning | |
| Rats | |
| Seeds | |
| Streptozocin |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30,262,975 | Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain. | Bioinformation | 2018 | https://conductscience.org/library/papers/30262975 | PubMed |
| 27,452,666 | Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy. | Semin Cancer Biol | 2016 | https://conductscience.org/library/papers/27452666 | PubMed |
| 22,654,956 | Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells. | Evid Based Complement Alternat Med | 2012 | https://conductscience.org/library/papers/22654956 | PubMed |
| 44,704 | Human monocyte killing of Staphylococcus aureus: modulation by agonists of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate. | Infect Immun | 1979 | https://conductscience.org/library/papers/44704 | PubMed |
| 40,226 | Testosterone and its precursors and metabolites enhance guanylate cyclase activity. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/40226 | PubMed |
| 24,847 | Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata). | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/24847 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20099
GET https://conductscience.org/api/papers/v1/20099/authors